✨
AI Summary
- New FDA CDER Director George Tidmarsh faces key challenges.
- Discussion on Sarepta's next steps following Elevidys issues.
- Analysis of the FDA's ongoing regulatory landscape.
Guests on This Episode
GT
George Tidmarsh
2 podcast appearances